In summary, we revealed that NAT10 promoted progression of DLBCL via mediating ac4C acetylation of SLC30A9 mRNA and regulating AMPK‐mTOR‐p70(S6K) signalling pathway (Figure 8). This evidence concerns the gene MTOR and diffuse large B-cell lymphoma.